Disease/Infection News

RSS

Alnylam Pharmaceuticals presents new data from its transthyretin-mediated amyloidosis program

Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that it presented new pre-clinical research findings from its transthyretin (TTR)-mediated amyloidosis (ATTR) program at the 60th Annual Meeting of the American Association for the Study of Liver Diseases (“The Liver Meeting”).

2 Nov 2009

Historic agreement sets national standard for containing the spread of H1N1

In a dramatic settlement seen as a novel pattern for the nation, the nation's largest nurses union and professional association, and one of the country's biggest hospital systems today announced a landmark agreement that sets a national standard on containing the spread of pandemics such as H1N1 "swine flu."

2 Nov 2009

NIAID awards Pulmatrix $2.2M grant for developing novel influenza therapeutics

Pulmatrix, a clinical stage biotechnology company discovering and developing a new class of therapies for the treatment and prevention of infectious and progressive respiratory diseases, today announced that it has been awarded a grant for $2.2 million from the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), aimed at advancing the development of novel influenza therapeutics for the treatment of seasonal and pandemic influenza.

2 Nov 2009

Canadian programs underscore evidence of PEGETRON's positive outcomes in treating HCV infection

Results from two significant Canadian studies underscore the growing scientific evidence of PEGETRON's positive outcomes in the treatment of chronic hepatitis C virus (HCV) infection. Canadian investigators across the country collaborated to generate and analyze clinical data from the Canadian PEGETRON POWeR (Prospective Optimal Weight-based Dosing Response) and REDIPEN programs, which were presented at the American Association for the Study of Liver Diseases (AASLD) Annual Meeting in Boston on November 1, 2009.

2 Nov 2009

Methacetin breath test predicts long-term survival in patients with chronic viral hepatitis

A methacetin breath test (MBT) that can be performed quickly and noninvasively has been proven to accurately predict survival in patients with viral hepatitis and may be used as an adjunctive tool to MELD.

2 Nov 2009

Rap video teaches kids how to avoid getting swine flu

"Blah, blah, H1N1 blah," is what many kids hear when their parents try to teach them how to avoid getting H1N1, or the swine flu. To cut through the blahs let DocRock and his H1N1 Rap teach your kids how to avoid catching H1N1 or the regular seasonal flu.

2 Nov 2009

AHF/Cambodia CARES to launch its AIDS testing initiative during the annual Water Festival

As part of an ambitious global effort to test several million people for HIV in observance of the Testing Millions World AIDS Day 2009 campaign, AHF/Cambodia CARES will launch its inaugural testing effort during the annual Water Festival, which marks the end of the rainy season and is the largest festival in the Cambodian calendar.

2 Nov 2009

Interim data from Bristol-Myers Squibb's BARACLUDE study for chronic hepatitis B patients

Bristol-Myers Squibb today announced 48-week data from an ongoing study (ETV-048) of chronic hepatitis B patients with decompensated cirrhosis, in which BARACLUDE demonstrated greater viral suppression compared to adefovir. The new BARACLUDE data were presented today at the 60th Annual Meeting of the American Association for the Study of Liver Diseases.

2 Nov 2009

Gilead Sciences to present Viread Phase III clinical trial data

Gilead Sciences, Inc. today announced the presentation of three-year (144-week) open label data from two pivotal Phase III clinical trials, Studies 102 and 103, evaluating the safety and efficacy of once-daily Viread® (tenofovir disoproxil fumarate) among adult patients with chronic hepatitis B virus (HBV) infection.

2 Nov 2009

Optimer Pharmaceuticals presents additional data from Phase 3 fidaxomicin study

Optimer Pharmaceuticals, Inc. today announced the presentation of new data from fidaxomicin's North American phase 3 study at the 47th Annual Meeting of the Infectious Diseases Society of America (IDSA) in Philadelphia, PA.

2 Nov 2009

MRSA bloodstream infection linked to high mortality rate

A strain of MRSA that causes bloodstream infections is five times more lethal than other strains and has shown to have some resistance to the potent antibiotic drug vancomycin used to treat MRSA, according to a Henry Ford Hospital study.

2 Nov 2009

Response and investigation of the outbreak of foodborne illnesses vary greatly

A survey of state health departments regarding their capacity to track produce-related foodborne illnesses found that the response and investigation of outbreaks varies greatly and can lead to delays in public-health response.

31 Oct 2009

RESPOND program to improve global perspective on emerging diseases

Experts from the University of Minnesota will soon be on the frontlines working to help developing countries better respond to emerging animal diseases that pose a threat to human health.

31 Oct 2009

AHF praises Obama for lifting travel ban on HIV-infected people

AIDS Healthcare Foundation (AHF) today lauded President Barack Obama for lifting a 22 year-old ban prohibiting HIV-positive foreigners from traveling to the US. The US was one of only twelve countries with such a travel ban. Obama announced repeal of the ban after signing the legislation renewing the Ryan White CARE Act, the federal law that authorizes the primary source of funding for AIDS care and services nationwide.

31 Oct 2009

Scientists report a major step forward in the development of an effective therapy against Nipah virus

A collaborative research team from the Uniformed Services University of the Health Sciences (USU), Australian Animal Health Laboratory and National Cancer Institute, a component of the National Institutes of Health, reports a major step forward in the development of an effective therapy against two deadly viruses, Nipah virus and the related Hendra virus.

31 Oct 2009

GAA welcomes Obama's announcement to lift HIV travel ban

The Global AIDS Alliance welcomes President Obama's announcement today to lift the 22 year-old U.S. travel and immigration ban on those living with HIV/AIDS. GAA Executive Director Paul Zeitz said "We congratulate President Obama on his decision to end this unfounded and discriminatory policy. This is an important sign of U.S. leadership and commitment."

31 Oct 2009

Canada's doctors thank government for easing sick note requirements during H1N1 pandemic

Canadian Medical Association President Dr. Anne Doig commended the federal government today for easing its requirements for sick notes during the H1N1 pandemic.

31 Oct 2009

New tools and interventions can help in eradicating malaria

Although malaria has been controlled in many local and regional populations, the permanent elimination of malaria parasites throughout the world remains an elusive goal, and the disease continues to claim nearly one million lives each year.

31 Oct 2009

Four abstracts on RSV and influenza prevention in pediatric health to be presented

MedImmune announced today it will present four abstracts at the 47th Annual Meeting of Infectious Disease Society of America (IDSA) being held here October 29 through November 1, 2009. These abstracts advance the body of data surrounding respiratory syncytial virus (RSV) and influenza prevention, highlighting MedImmune's leadership in pediatric health.

31 Oct 2009

Patients who acquire SSTIs in healthcare settings may stay longer in hospitals to control the infection

Patients who acquire skin and soft tissue infections (SSTIs) in a hospital or other healthcare setting may be more likely to receive inappropriate antibiotic therapy at the beginning of their treatment. As a result, they also may have significantly longer hospital stays to control the infection.

31 Oct 2009

Disease/Infection News

Alnylam Pharmaceuticals presents new data from its transthyretin-mediated amyloidosis program

Historic agreement sets national standard for containing the spread of H1N1

NIAID awards Pulmatrix $2.2M grant for developing novel influenza therapeutics

Canadian programs underscore evidence of PEGETRON's positive outcomes in treating HCV infection

Methacetin breath test predicts long-term survival in patients with chronic viral hepatitis

Rap video teaches kids how to avoid getting swine flu

AHF/Cambodia CARES to launch its AIDS testing initiative during the annual Water Festival

Interim data from Bristol-Myers Squibb's BARACLUDE study for chronic hepatitis B patients

Gilead Sciences to present Viread Phase III clinical trial data

Optimer Pharmaceuticals presents additional data from Phase 3 fidaxomicin study

MRSA bloodstream infection linked to high mortality rate

Response and investigation of the outbreak of foodborne illnesses vary greatly

RESPOND program to improve global perspective on emerging diseases

AHF praises Obama for lifting travel ban on HIV-infected people

Scientists report a major step forward in the development of an effective therapy against Nipah virus

GAA welcomes Obama's announcement to lift HIV travel ban

Canada's doctors thank government for easing sick note requirements during H1N1 pandemic

New tools and interventions can help in eradicating malaria

Four abstracts on RSV and influenza prevention in pediatric health to be presented

Patients who acquire SSTIs in healthcare settings may stay longer in hospitals to control the infection

How can microdialysis benefit drug development

Global and Local Efforts to Take Action Against Hepatitis

Addressing Important Cardiac Biology Questions with Shotgun Top-Down Proteomics

Latest News